BioSpace News Archive

Deals

WindRose Health Investors Completes Recapitalization of Lykan Bioscience Holdings, LLC

WindRose Health Investors, LLC, the New York-based healthcare private equity firm, announced the completion of an equity recapitalization of Lykan Bioscience Holdings, LLC.

June 4, 2019
·
2 min read
Clinical Results From CollPlant’s Advanced Wound Care Product VergenixFG to Be Presented at European Wound Management Association Conference

CollPlant, a regenerative medicine company, announced that the results from a clinical study conducted with its VergenixFG advanced wound care product will be presented at the 29th Conference of the European Wound Management Association.

June 4, 2019
·
5 min read
Policy

Proteostasis Therapeutics Receives Orphan Drug Designation in the EU for PTI-428 for the Treatment of Cystic Fibrosis

Proteostasis Therapeutics, Inc. announced that the European Commission has granted orphan drug designation to PTI-428 for the treatment of cystic fibrosis.

June 4, 2019
·
5 min read
Business

Bayer and Arvinas, Inc. to develop novel Proteolysis-Targeting Chimera candidates for humans and plants

Bayer announced a collaboration with Arvinas, Inc., a biopharmaceutical company based in New Haven, Connecticut.

June 4, 2019
·
7 min read
Job Trends

$10.7 Billion: More Biotech Firms, More Life Research, More Jobs and Higher Industry Wages in Oregon Make an Increasingly Larger Economic Impact in Oregon

Oregon Bioscience Association releases its new economic impact report which points to a highly diverse workforce, combined $10.7 billion footprint and continued notable gains in wages and jobs touching virtually every other sector in the economy, including $1.1 billion in state and federal taxes paid and $3.9 billion in exports

June 4, 2019
·
6 min read
Deals

Dr. Reddy’s Laboratories Limited Announces Filing of Annual Report on Form 20-F - June 4, 2019

Dr. Reddy’s Laboratories Limited announced that its Annual Report on Form 20-F, containing its annual consolidated financial statements for the fiscal year ended March 31, 2019 was filed with the United States Securities and Exchange Commission on June 3, 2019.

June 4, 2019
·
2 min read
Deals

A Step Forward For Digital Identity: CertiPath And ZEVA Acquire SAFE-BioPharma

CertiPath and ZEVA have jointly acquired SAFE-BioPharma.

June 4, 2019
·
2 min read
Biotech Beach

Innovus Pharma Expands its OTC Drug Pipeline with the Addition of OmepraCare™ (a Competitor of Prilosec® OTC)

This New Drug OmepraCare™ is Indicated for the Treatment of Frequent Heartburn and is Expected to add Significant Revenue to the Company

June 4, 2019
·
4 min read
Job Trends

Magellan Rx Management Launches Oncology Biosimilar Medical Pharmacy Solution, Aims to Improve Member Access, Reduce Costs and Save Customers Millions in Drug Spend

Magellan Rx Management announced the launch of a medical pharmacy solution targeting oncology therapeutic biosimilars.

June 4, 2019
·
4 min read
Policy

Ra Pharmaceuticals Announces Expansion of Neuromuscular Portfolio with Clearance of IND Application for Zilucoplan for the Treatment of Immune-Mediated Necrotizing Myopathy

Multi-center Phase 2 clinical trial on track to initiate in the second half of 2019

June 4, 2019
·
6 min read